ORAMED PHARMACEUTICALS INC. — Cash Flow Charts
25 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-138.4% -$2M
$-4M
Free Cash Flow↑+81.8% +$9K
$-2K
Investing Cash Flow
$38M
Financing Cash Flow
$50M
Capex↓-81.8% -$9K
$2K
Stock Buybacks↑+236.0% +$3M
$4M
Stock-Based Comp↑+85.8% +$1M
$2M
Debt Repaid↓-100.0% -$25M
$0
D&A↓-3.2% -$1K
$30K
SBC Allocated Expense↑+85.8% +$1M
$2M